Access & Channel

Perpectives on Orphan-Drug Development

BPI Magazine's Cheryl Scott discusses orphan-drug development with industry experts.

REPORT: COVID-19 One Year On - Impacts on the Global Life Sciences Industry 2021

Patient Services: Six strategies for optimizing cross-functional collaboration between compliance and access

Five industry experts from compliance and patient services explore how leading organizations promote better collaboration, communication, and patient outcomes in this whitepaper.

What does it mean to be patient centered in health economics?

As the movement towards more patient-centered health care gains momentum, how does health economics sit at this intersection between cost-effective care and patient-centered care?

Life Sciences Survey: COVID-19 Impacts One Year On

Take part in our industry survey on the impacts of COVID-19 on the life sciences one year on to get exclusive early access to the final report.

Case Management for Novel and Innovative Therapies

Case Management for Novel and Innovative Therapies - Executive summary from the Patient Support Services virtual event.

REPORT: Diversity, Equity and Inclusion in the Life Sciences 2021

Explore the Diversity, Equity and Inclusion in the Life Sciences 2021 report based on an exclusive study of 483 industry professionals.

Navigating COVID-19: Critical success factors for helping providers overcome patient access and reimbursement challenges

Explore the key takeaways from a PAP 2020 panel discussion on the critical success factors for helping providers overcome patient access and reimbursement challenges created by COVID-19

SURVEY: Diversity, Equity and Inclusion in the Life Sciences 2021

Complete our survey on Diversity, Equity and Inclusion in the Life Sciences 2021 to get exclusive early access to the final report.

HCP Promotional Engagement Benchmarks Report — Special Edition: Pre-Pandemic Snapshot and COVID-19 Impact Evaluation

This year’s annual analysis of life sciences promotional speaker programming
data is quite different from previous years’ snapshots. The COVID-19 pandemic
has upended industries around the world; life sciences is no exception.

Independent Charitable Copay Foundation Donations: What to Consider and Steps to Take Before Donating and What Recent Court Challenges Might Mean for Industry

From our recent Patient Support Services 2020, Katherine Chaurette of Blueprint Medicines and Rahul Khara of Acceleron Pharma Inc. dive into an overview and brief background of the OIG Guidance, manufacturer and foundation enforcement actions, compliance considerations and so much more in this presentation on Independent Charitable Copay Foundation Donations.

Pricing & Reimbursement US 2020

Whether a drug product is covered, and at what price, is determined by each payer’s coverage, coding, and payment criteria for health insurance plans. The largest government-funded
programs are Medicare and Medicaid, under which plans are subject to detailed requirements set forth by statute or regulation.